Ezetimibe Impurity 75 | CAS 40339-46-6 - Request Quote
Ezetimibe Impurity 75
| SZ CAT No: | SZ-E026151 |
| CAS No | 40339-46-6 |
| Mol.F. | C13H11NO |
| Mol.Wt. | 197.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ezetimibe Impurity 75 is chemically (Z)-4-((phenylimino)methyl)phenol. Ezetimibe Impurity 75 is supplied with detailed characterization data compliant with regulatory guideline. Ezetimibe Impurity 75 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ezetimibe.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 40339-46-6
Purchase 40339-46-6
Order 40339-46-6
Enquire 40339-46-6
price of 40339-46-6
40339-46-6 Supplier
40339-46-6 Manufacturer
40339-46-6 Exporter
buy high quality Ezetimibe Impurity 75
Purchase Ezetimibe Impurity 75
Ezetimibe Impurity 75 suppliers
Ezetimibe Impurity 75 manufacturers
Ezetimibe Impurity 75 price
Order Ezetimibe Impurity 75
Enquire Ezetimibe Impurity 75
Ezetimibe Impurity 75 cost
Ezetimibe Impurity 75 Supplier
Ezetimibe Impurity 75 Distributor
Ezetimibe Impurity 75 for Method Validation
Ezetimibe Reference Standard
Ezetimibe Impurity 75 for ANDA Filing
Ezetimibe Impurity 75 for Forced Degradation Studies
Ezetimibe Impurity 75 Identification Standards
Ezetimibe Impurity 75 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


